Annovis Bio (NYSE:ANVS) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.40) by 7.5 percent. This is a 81.55 percent increase over losses of $(2.33) per share from the same period last year.
Annovis Bio (NYSE:ANVS) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.40) by 7.5 percent. This is a 81.55 percent increase over losses of $(2.33) per share from the same period last year.
Comments